However, the existence of several molecularly and prognostically distinct subtypes of IDH-wildtype glioblastomas, and their highly infiltrative nature may contribute to the difficulties in finding an effective and tailored treatment for them. This evidence concerns the gene IDH1 and glioblastoma.